Charlotte Pahl

Direktor/Vorstandsmitglied bei Reponex Pharmaceuticals A/S

Vermögen: 129 741 $ am 30.04.2024

Health Technology

Aktive Positionen von Charlotte Pahl

Unternehmen	Position	Beginn	Ende
Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	Direktor/Vorstandsmitglied	-	-

International

Dänemark

Operativ

Director/Board Member

Sektoral

Health Technology

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	Health Technology

Private Unternehmen

Health Technology